Andrographis for Immune Health: The King of Bitters for Colds and Inflammation

Andrographis (Andrographis paniculata), known as "the king of bitters" in Ayurvedic and traditional Chinese medicine, is one of the most clinically validated herbal treatments for upper respiratory tract infections (URTIs). Its primary active compound, andrographolide, has demonstrated potent antiviral, anti-inflammatory, and immunostimulatory properties in dozens of human clinical trials.

Quick Answer

Andrographis extract (standardized to andrographolides) at 200–400 mg daily has strong clinical evidence for reducing the severity and duration of colds and upper respiratory infections. A Cochrane review and multiple meta-analyses support its efficacy. It is most effective when started within 36–48 hours of symptom onset. It also has emerging benefits for inflammation, liver health, and autoimmune conditions.

Mechanism of Action

Andrographolide and its derivatives work through multiple immune and anti-inflammatory pathways:

• NF-kB inhibition: Andrographolide directly binds to and inhibits NF-kB, the master inflammatory transcription factor. This is one of the most potent natural NF-kB inhibitors identified
• Immune cell activation: Stimulates macrophage phagocytosis, natural killer cell activity, and antibody production
• Antiviral: Inhibits viral replication through multiple mechanisms, including interference with viral RNA-dependent RNA polymerase
• Anti-inflammatory cytokine modulation: Reduces TNF-alpha, IL-1beta, IL-6 while promoting anti-inflammatory IL-10
• COX-2 and iNOS inhibition: Reduces prostaglandin and nitric oxide overproduction in inflammatory states

Clinical Evidence

Upper Respiratory Infections

This is the most robust evidence base:

• A 2004 Cochrane-quality review of 7 double-blind RCTs (896 patients) found Andrographis significantly reduced URTI symptom severity including sore throat, nasal discharge, and cough
• A 2017 meta-analysis in Clinical and Experimental Pharmacology and Physiology confirmed significant reductions in cough, sore throat, and overall cold severity
• Kan Jang (Andrographis + Eleutherococcus) is the most studied formulation, showing consistent benefit across multiple Swedish and Eastern European trials
• A 2010 study found Andrographis reduced cold duration by 2.1 days vs. placebo
• Effectiveness comparable to paracetamol for cold symptom relief in a head-to-head trial

Pharyngotonsillitis (Sore Throat)

• A double-blind study compared Andrographis (6 g/day of dried herb) to paracetamol for fever and sore throat. By day 3, Andrographis was comparable in symptom reduction

Inflammatory Conditions

• A 2009 pilot study found Andrographis extract (Paractin) reduced symptoms in rheumatoid arthritis
• A 2010 trial in ulcerative colitis showed 1,200 mg of Andrographis extract daily was non-inferior to mesalazine for inducing remission (UC trial by HMPL-004)
• Emerging evidence for metabolic inflammation and liver protection

Prevention

• A double-blind study of 107 students found 200 mg daily of Andrographis extract for 3 months reduced cold incidence by 33% compared to placebo

Dosing

For Acute Infections (Treatment)

• Standardized extract: 400–1,200 mg daily (standardized to 10–30% andrographolides)
• Andrographolide-specific: 48–120 mg andrographolides daily
• Start immediately: Most effective when begun within 36–48 hours of symptom onset
• Duration: 5–10 days for acute infections
• Divide doses: 3–4 times daily for acute use

For Prevention

• Lower dose: 200 mg daily of standardized extract
• Duration: Throughout cold/flu season
• Combine with: Vitamin C, zinc, or elderberry for multi-targeted prevention

Clinically Studied Formulations

• Kan Jang: Andrographis + Eleutherococcus (most evidence)
• KalmCold: Standardized Andrographis extract
• Paractin: Standardized to 30% andrographolides
• HMPL-004: Used in the UC clinical trial

Safety and Side Effects

Andrographis is generally safe but has some notable considerations:

• Bitter taste: Extremely bitter — capsules are strongly preferred over liquid preparations
• GI effects: Nausea, vomiting, and loss of appetite are the most common side effects, especially at higher doses
• Allergic reactions: Urticaria (hives) and anaphylaxis have been rarely reported — discontinue if rash develops
• Anticoagulant effect: Inhibits platelet aggregation — use caution with blood thinners and before surgery
• Blood pressure: May lower blood pressure — monitor if on antihypertensives
• Fertility: High-dose animal studies showed anti-fertility effects in both sexes. Not recommended for those actively trying to conceive
• Pregnancy: Contraindicated — traditional use as an abortifacient
• Autoimmune disease: The immune-stimulating effects may theoretically worsen some autoimmune conditions, though the UC trial suggests nuance here

FAQ

Q: Is Andrographis as effective as echinacea for colds? Head-to-head data is limited, but Andrographis generally has stronger and more consistent clinical evidence for URTI symptom reduction. A systematic comparison suggested Andrographis was at least as effective as echinacea, with better-designed supporting trials.

Q: Can I take Andrographis with cold medications (Tylenol, DayQuil)? Andrographis can generally be combined with OTC cold remedies, though the blood-thinning effect means caution with aspirin-containing products. The combination with paracetamol (acetaminophen) has been studied without issues.

Q: Should I take Andrographis every day or only when sick? Both approaches have evidence. Daily low-dose use (200 mg) prevented colds in the prevention trial. Higher-dose acute use (400–1,200 mg) is the most common approach — keeping it available for the first sign of illness and starting immediately.

Related Articles

• Cat's Claw Immune Guide
• Elderberry Benefits
• Vitamin C Benefits
• Zinc Benefits Guide

Track your supplements in Optimize.